{"id":70705,"date":"2026-05-12T09:29:41","date_gmt":"2026-05-12T09:29:41","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=70705"},"modified":"2026-10-15T10:33:58","modified_gmt":"2026-10-15T10:33:58","slug":"oxytocin-acetate","status":"publish","type":"product","link":"https:\/\/medsbase.com\/it\/product\/oxytocin-acetate\/","title":{"rendered":"Ossitocina Acetato"},"content":{"rendered":"<p><!-- medsbase-tldr-answer --><\/p>\n<div style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<h3 style=\"margin: 0 0 8px 0; font-size: 16px; color: #1a4a6b;\">Risposta rapida \u2014 Cos'\u00e8 l'Oxytocin Acetate?<\/h3>\n<p style=\"margin: 0;\"><strong>Ossitocina Acetato<\/strong> is the acetate-salt form of oxytocin, a 9-amino-acid cyclic neuropeptide with a single disulfide bridge between Cys1 and Cys6. It is one of the oldest and most extensively studied neuropeptides in published studies, acting as both a hypothalamic hormone (uterine contraction, milk ejection) and a central neuromodulator of social bonding, trust, and affiliative behaviour. Supplied in 5\u00a0mg and 10\u00a0mg lyophilized vials.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>Cosa ottieni con MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/it\/reviews\/\">recensioni dei clienti<\/a><\/div>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Ogni ordine \u00e8 coperto dalla nostra <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\"><strong>Politica di Garanzia di Rispedizione<\/strong><\/a> \u2014 se il tuo pacco non arriva entro 20 giorni lavorativi, lo rispediamo.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Specifiche<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Dettaglio<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Numero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">50-56-6 (ossitocina base libera); fornito come forma di sale acetato<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Formula Molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">C<sub>43<\/sub>H<sub>66<\/sub>N<sub>12<\/sub>O<sub>12<\/sub>S<sub>2<\/sub> (base libera; il sale acetato aggiunge CH<sub>3<\/sub>COOH controione)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso molecolare<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">1007.19 Da (base libera)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequenza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Cys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly-NH<sub>2<\/sub> (CYIQNCPLG-NH<sub>2<\/sub>, 9 amminoacidi; ponte disolfuro intramolecolare Cys<sup>1<\/sup>\u2013Cys<sup>6<\/sup> formando un anello macrociclico a 6 residui con una coda C-terminale a 3 residui; C-terminale amidato)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Sale acetato liofilizzato (polvere bianca o biancastra)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Purezza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (verificato con HPLC, COA disponibile su richiesta)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Conservazione<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Liofilizzato: 2\u20138 \u00b0C (frigorifero) per lo stock di lavoro; \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Ricostituito: 2\u20138 \u00b0C, utilizzare entro ~30 giorni. Proteggere dalla luce. Non congelare e scongelare la soluzione ricostituita.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilit\u00e0<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Bacteriostatic water (recommended) or sterile water for shorter use windows. Compatible with intranasal vehicle formulations.<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><!-- \/medsbase-tldr-answer --><\/p>\n<h2>Cos'\u00e8 l'Acetato di Ossitocina?<\/h2>\n<p><strong>Ossitocina Acetato<\/strong> is the acetate-salt form of oxytocin, a 9-amino-acid cyclic neuropeptide first isolated by Sir Henry Dale in 1906 and chemically synthesised by Vincent du Vigneaud in 1953 \u2014 the first peptide hormone ever produced by total synthesis, work that earned du Vigneaud the 1955 Nobel Prize in Chemistry. The acetate counterion is used in pharmaceutical-grade lyophilization because it improves long-term peptide stability and water solubility relative to free-base oxytocin without altering pharmacology \u2014 the acetate dissociates rapidly in physiological solution. The well-characterised sequence is CYIQNCPLG-NH<sub>2<\/sub> con un ponte disolfuro intramolecolare tra Cys1 e Cys6 che crea un anello macrociclico a 6 residui e una coda C-terminale a 3 residui. Il peso molecolare \u00e8 1007.19 Da (base libera); formula empirica C<sub>43<\/sub>H<sub>66<\/sub>N<sub>12<\/sub>O<sub>12<\/sub>S<sub>2<\/sub>. Oxytocin is supplied as a high-purity lyophilized powder for reconstitution with bacteriostatic water. For related small-peptide CNS studies, see our <a href=\"https:\/\/medsbase.com\/it\/selank\/\">Selank<\/a> e <a href=\"https:\/\/medsbase.com\/it\/pt-141\/\">PT-141<\/a> Ci\u00f2 che differenzia il tirzepatide dai precedenti peptidi a incretina singola \u00e8 il suo. <\/p>\n<h2>Meccanismo d'Azione \u2014 Ruoli Endocrini Periferici e di Neuromodulatore Centrale<\/h2>\n<p>What makes oxytocin unusual among peptides is its <strong>doppia identit\u00e0<\/strong> come ormone endocrino periferico e neuromodulatore centrale. La stessa molecola, rilasciata da diversi compartimenti anatomici, produce effetti fisiologici fondamentalmente diversi:<\/p>\n<ul>\n<li><strong>Rilascio endocrino periferico \u2014 effetti uterini e mammari<\/strong> \u2014 L'ossitocina viene sintetizzata nei neuroni magnocellulari dei nuclei ipotalamici sopraottico e paraventricolare e rilasciata nella circolazione sistemica dalla neuroipofisi posteriore. L'ossitocina periferica si lega ai recettori OXTR sulla muscolatura liscia uterina (stimolando le contrazioni durante il travaglio) e sulle cellule mioepiteliali degli alveoli mammari (favorendo il riflesso di eiezione del latte). L'emivita periferica \u00e8 breve (~3-5 minuti per via endovenosa) a causa del rapido metabolismo da parte dell'ossitocinasi e altre peptidasi.<\/li>\n<li><strong>Rilascio centrale \u2014 comportamenti sociali, affiliativi e di mitigazione dello stress<\/strong> \u2014 A separate population of parvocellular oxytocin neurons projects axonally into brain regions including the amygdala, nucleus accumbens, ventral tegmental area, and prefrontal cortex. Central oxytocin release does not enter systemic circulation and is not measured by plasma assays. In published studies it modulates pair-bonding, in-group affiliation, trust, fear extinction, and stress reactivity. The prairie-vole pair-bonding literature is the canonical mechanistic dataset for central oxytocin signalling.<\/li>\n<li><strong>Farmacologia recettoriale e trasduzione del segnale<\/strong> \u2014 L'ossitocina agisce su un singolo recettore accoppiato a proteina G (OXTR), che si accoppia principalmente a G\u03b1<sub>q\/11<\/sub> per attivare la fosfolipasi C, IP<sub>3<\/sub>, e il rilascio di calcio intracellulare nella muscolatura liscia. Nel SNC, la segnalazione OXTR \u00e8 pi\u00f9 complessa e include l'accoppiamento G\u03b1<sub>i\/o<\/sub> coupling, modulation of GABAergic interneurons, and crosstalk with the closely-related vasopressin V1a receptor. Selective OXTR agonists and antagonists are heavily used in current studies to dissect oxytocin vs vasopressin contributions to behaviour.<\/li>\n<\/ul>\n<p>The intranasal administration route is one of the most-cited studies delivery methods because it produces measurable CNS effects on social behaviour without raising peripheral plasma oxytocin to physiologically meaningful levels. The exact mechanism by which intranasal oxytocin reaches CNS compartments \u2014 whether through olfactory and trigeminal nerve transport, cribriform plate diffusion, or a peripheral feedback signal \u2014 remains an active studies question. The behavioural effects are reproducible enough that intranasal administration has become the standard route in human and rodent oxytocin behavioural support. <\/p>\n<h2>Published Evidence<\/h2>\n<p>Oxytocin Acetate is used in clinical contexts that investigate:<\/p>\n<ul>\n<li><strong>Comportamento sociale e formazione di legami di coppia<\/strong> \u2014 test di preferenza del partner nei topi delle praterie, formazione di preferenze del partner in topi monogami vs poligami, paradigmi di riconoscimento sociale nei roditori (Insel &amp; Hulihan, Behav Neurosci 1995; Young &amp; Wang, Nat Neurosci 2004)<\/li>\n<li><strong>Autism spectrum and social-cognition studies<\/strong> \u2014 preclinical models of social-deficit phenotypes, OXTR variant cohort studies, intranasal oxytocin behavioural endpoints; one of the most active areas of contemporary oxytocin clinical studies<\/li>\n<li><strong>Trust and cooperation behavioural support<\/strong> \u2014 paradigmi economici del gioco della fiducia, processo decisionale cooperativo in condizioni di incertezza; modulazione del bias tra gruppo interno ed esterno<\/li>\n<li><strong>Stress, ansia ed estinzione della paura<\/strong> \u2014 amygdala-dependent fear conditioning, stress-induced HPA-axis activation, cortisol response modulation in published studies<\/li>\n<li><strong>Comportamento materno e cure parentali<\/strong> \u2014 postpartum maternal-behaviour induction in rodents, paternal-care studies in monogamous vole species, alloparental behaviour<\/li>\n<li><strong>Reproductive physiology studies<\/strong> \u2014 uterine contractility assays, mammary myoepithelial-cell studies, labour and parturition mechanism studies<\/li>\n<li><strong>Guarigione delle ferite e rigenerazione tissutale<\/strong> \u2014 OXTR expression on dermal fibroblasts and keratinocytes; emerging studies on local oxytocin signalling in cutaneous wound repair<\/li>\n<li><strong>Comparative neuropeptide studies<\/strong> \u2014 confronto con la vasopressina (un neuropeptide ciclico a 9 aa strettamente correlato con una differenza di un amminoacido) e con altri piccoli peptidi attivi nel SNC come <a href=\"https:\/\/medsbase.com\/it\/selank\/\">Selank<\/a>.<\/li>\n<\/ul>\n<p>Per un contesto pi\u00f9 ampio su dove si colloca l'ossitocina nel panorama dei neuromodulatori a piccoli peptidi, vedere <a href=\"https:\/\/medsbase.com\/it\/selank\/\">Selank<\/a> (eptapeptide ansiolitico), <a href=\"https:\/\/medsbase.com\/it\/pt-141\/\">PT-141<\/a> (agonista delle melanocortine attivo nel SNC), e <a href=\"https:\/\/medsbase.com\/it\/semax\/\">Semax<\/a> (eptapeptide nootropo). Esplora l'intera <a href=\"https:\/\/medsbase.com\/it\/peptides\/\">catalogo peptidi<\/a> per composti correlati. <\/p>\n<h2>Concentrazioni e Dosaggi Disponibili<\/h2>\n<p>MedsBase stocks Oxytocin Acetate in two lyophilized vial sizes calibrated to typical protocol lengths. Each strength is available in 10-vial, 20-vial, or 30-vial pack formats with full reconstitution guidance:<\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dosaggio per Flaconcino<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Caso d'Uso Tipico<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Dimensioni della Confezione<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>5 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Standard strength, intranasal-vehicle formulation, behavioural-test protocols<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>10 mg<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Extended-cycle studies, lowest per-mg cost, multi-cohort behavioural studies<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">10, 20 o 30 fiale<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Both strengths are the same chemical form (lyophilized acetate-salt powder, 99%+ HPLC purity). Because oxytocin&#8217;s dose range is in the low-microgram-per-administration regime, a single 5\u00a0mg vial supports many weeks of behavioural support at typical intranasal doses (24\u00a0IU \u2248 40\u00a0mcg per administration in human studies, with rodent doses scaled lower). <\/p>\n<h2>Confronto \u2014 Acetato di Ossitocina vs Selank<\/h2>\n<p>L'ossitocina e <a href=\"https:\/\/medsbase.com\/it\/selank\/\">Selank<\/a> are both small CNS-active peptides used in behavioural and mood-axis studies, but they target different receptors and behavioural domains. They are sometimes compared in studies because both are intranasally bioavailable and both produce measurable behavioural effects in published rodent and human studies despite being structurally and pharmacologically unrelated. <\/p>\n<table style=\"width: 100%; border-collapse: collapse; margin: 16px 0;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Criterio<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Ossitocina Acetato<\/th>\n<th style=\"padding: 10px; border: 1px solid #ddd; text-align: left;\">Selank<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Lunghezza<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">9 amminoacidi (nonapeptide ciclico)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">7 amminoacidi (eptapeptide lineare)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Struttura<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Macrociclo con ponte disolfuro<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Lineare con C-terminale amidato<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Recettore primario<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">OXTR (accoppiato a proteina G)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Non classico (modulazione GABA, BDNF)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Segnale comportamentale<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Legame sociale, fiducia, comportamento affiliativo<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiolitico, resilienza allo stress<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Typical dose (intranasal)<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">24\u201340 UI (~40\u201365 mcg)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">300\u2013900 mcg<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Emivita plasmatica<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~3\u20135 min (EV)<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">~15\u201330 min (intranasale)<\/td>\n<\/tr>\n<tr>\n<td style=\"padding: 10px; border: 1px solid #ddd;\"><strong>Uso clinico approvato<\/strong><\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Induzione del travaglio, emorragia post-partum<\/td>\n<td style=\"padding: 10px; border: 1px solid #ddd;\">Ansiolitico (solo in Russia)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>For behavioural-stacking, the two peptides have non-overlapping mechanisms (oxytocin acts on its own GPCR; Selank acts via GABA\/BDNF modulation), so co-administration is not pharmacologically redundant. Study protocols studying stress and social behaviour as joint endpoints sometimes use both arms. <\/p>\n<h2>Conservazione e ricostituzione<\/h2>\n<p><strong>Prima della ricostituzione:<\/strong> conservare i flaconcini liofilizzati refrigerati a 2\u20138 \u00b0C nella confezione originale per lo stock di lavoro a breve termine. Per lo stoccaggio a lungo termine non aperto, congelare a \u221220 \u00b0C. L'ossitocina acetato liofilizzata \u00e8 stabile in refrigerazione fino a 24 mesi e a \u221220 \u00b0C fino a 36 mesi. Evitare cicli di congelamento-scongelamento sulla polvere liofilizzata. La forma acetato \u00e8 pi\u00f9 igroscopicamente stabile della base libera, ma i flaconcini devono comunque essere protetti dall'umidit\u00e0 atmosferica. <strong>Procedura di ricostituzione:<\/strong> inject bacteriostatic water down the side wall of the peptide vial (not directly onto the lyophilized cake). For a 5\u00a0mg vial, 5.0\u00a0mL of bacteriostatic water yields a 1\u00a0mg\/mL working concentration; 0.04\u00a0mL delivers a 40\u00a0mcg dose (~24\u00a0IU). Swirl gently \u2014 do <strong>not<\/strong> shake \u2014 and allow 2\u20135 minutes for full dissolution. A correctly reconstituted solution should be clear and colourless. For intranasal-vehicle formulations, the reconstituted solution can be transferred to a calibrated nasal-spray bottle delivering ~100\u00a0\u03bcL per pump. <strong>Dopo la ricostituzione:<\/strong> conservare in frigorifero a 2\u20138 \u00b0C e utilizzare entro 30 giorni per una stabilit\u00e0 ottimale. Non congelare la soluzione ricostituita \u2014 i cicli di congelamento-scongelamento degradano l'integrit\u00e0 del peptide e interrompono il legame disolfuro Cys1\u2013Cys6. Scartare qualsiasi flaconcino che presenti torbidit\u00e0, precipitato o scolorimento. <\/p>\n<h2 id=\"faqs\">Domande frequenti<\/h2>\n<h3>What is Oxytocin Acetate used for in studies?<\/h3>\n<p>Oxytocin Acetate is used in studies investigating social behaviour and pair-bonding, autism spectrum and social cognition, trust and cooperation paradigms, stress and fear extinction, maternal and parental care, reproductive physiology, and wound healing. It is one of the most extensively studied neuropeptides in the published literature and serves as the canonical OXTR-axis compound. The pharmaceutical-grade oxytocin acetate sold here is <strong>not<\/strong> FDA-approved for non-clinical human use and is supplied strictly for clinical studies. <\/p>\n<h3>Qual \u00e8 la differenza tra oxytocin acetate e oxytocin in forma libera?<\/h3>\n<p>The acetate counterion does not alter pharmacology \u2014 it dissociates rapidly in physiological solution. The acetate salt is used in pharmaceutical-grade peptide lyophilization because it improves long-term peptide stability, reduces hygroscopicity, and improves aqueous solubility relative to free-base oxytocin. All published behavioural and endocrine effects of oxytocin apply to the acetate salt at equivalent oxytocin content. <\/p>\n<h3>In cosa differisce l'Oxytocin dal Selank?<\/h3>\n<p>Both are small CNS-active peptides used in behavioural support, but they target different receptors and behavioural domains. Oxytocin is a 9-amino-acid disulfide-bridged macrocyclic peptide that binds the OXTR G-protein-coupled receptor, with primary signal in social bonding and trust paradigms. Selank is a 7-amino-acid linear heptapeptide that acts via GABA modulation and BDNF expression, with primary signal in anxiolysis and stress resilience. The two are pharmacologically unrelated. <\/p>\n<h3>What is the typical Oxytocin dose?<\/h3>\n<p>Published human intranasal protocols typically use 24\u201340\u00a0IU per administration (1\u00a0IU \u2248 1.7\u00a0mcg, so 24\u00a0IU \u2248 40\u00a0mcg). Rodent doses are scaled lower in absolute mass but higher in mg\/kg. A 5\u00a0mg vial reconstituted with 5.0\u00a0mL bacteriostatic water yields 1\u00a0mg\/mL \u2014 40\u00a0mcg per 0.04\u00a0mL. <\/p>\n<h3>L'Oxytocin Acetate \u00e8 approvato dalla FDA?<\/h3>\n<p>Pharmaceutical injectable oxytocin (Pitocin, Syntocinon) is FDA-approved for specific obstetric indications \u2014 labour induction, postpartum haemorrhage control, and milk-letdown facilitation \u2014 manufactured to GMP standards by approved pharmaceutical manufacturers. <\/p>\n<h3>Come deve essere conservato l'Oxytocin Acetate?<\/h3>\n<p>Flaconcini liofilizzati: refrigerati a 2\u20138 \u00b0C per lo stock di lavoro a breve termine, o \u221220 \u00b0C per lo stoccaggio a lungo termine di flaconcini non aperti. Soluzione ricostituita: refrigerata a 2\u20138 \u00b0C, utilizzare entro 30 giorni. Non congelare la soluzione ricostituita \u2014 i cicli di congelamento-scongelamento degradano il peptide e possono interrompere il ponte disolfuro. Proteggere dalla luce diretta in ogni momento. <\/p>\n<h3>Come si ricostituisce l'Oxytocin Acetate?<\/h3>\n<p>Seguire la procedura di ricostituzione sopra indicata. Aggiungere acqua batteriostatica lungo la parete laterale del flaconcino (non direttamente sulla polvere liofilizzata), agitare delicatamente e attendere 2-5 minuti per la completa dissoluzione. Non <strong>not<\/strong> agitare la fiala \u2014 un'agitazione vigorosa pu\u00f2 compromettere il legame disolfuro. Una soluzione ricostituita correttamente \u00e8 limpida e incolore. Per una fiala da 5 mg + 5,0 mL di diluente, la concentrazione di lavoro \u00e8 di 1 mg\/mL. <\/p>\n<h3>Quali dosaggi sono disponibili su MedsBase?<\/h3>\n<p>MedsBase carries Oxytocin Acetate in 5\u00a0mg and 10\u00a0mg lyophilized vials. Each strength is available in 10-vial, 20-vial, or 30-vial pack sizes. All vials are supplied at 99%+ HPLC purity with a certificate of analysis available on request. <\/p>\n<h3>Can Oxytocin be administered intranasally in studies?<\/h3>\n<p>Yes \u2014 intranasal administration is one of the most-cited studies delivery routes for oxytocin behavioural studies. Intranasal oxytocin produces measurable CNS effects on social behaviour, trust, and stress reactivity without raising peripheral plasma oxytocin to physiologically meaningful levels. The exact mechanism of CNS access remains an active studies question (olfactory and trigeminal nerve transport, cribriform plate diffusion, or peripheral feedback). Subcutaneous and intracerebroventricular routes are also documented in rodent studies. <\/p>\n<h3>Qual \u00e8 l'emivita dell'ossitocina?<\/h3>\n<p>In published studies, oxytocin has a plasma half-life of approximately 3\u20135 minutes following intravenous administration. The short peripheral half-life is due to rapid metabolism by oxytocinase (also called cystinyl aminopeptidase) and other peptidases. Behavioural effects following intranasal administration outlast plasma clearance because central oxytocin compartments are distinct from peripheral circulation. <\/p>\n<h3>Perch\u00e9 il ponte disolfuro \u00e8 importante?<\/h3>\n<p>Il legame disolfuro Cys1\u2013Cys6 blocca l'ossitocina nella conformazione ciclica necessaria per il legame al recettore. La riduzione del legame disolfuro converte l'ossitocina in una forma lineare inattiva \u2014 ecco perch\u00e9 le procedure di ricostituzione evitano specificamente agitazioni vigorose e cicli di congelamento-scongelamento, che possono compromettere il ponte e degradare l'attivit\u00e0 del peptide. Il neuropeptide strettamente correlato vasopressina ha la stessa architettura del ponte disolfuro con una sola differenza aminoacidica in posizione 3 (Phe nella vasopressina vs Ile nell'ossitocina). <\/p>\n<h3>Does Oxytocin cause side reported effects?<\/h3>\n<p>The most consistent finding in oxytocin is dose-dependence of behavioural effects \u2014 the response is not monotonic at high doses, and very large doses can produce paradoxical effects. Acute peripheral effects can include uterine contraction (relevant in pregnancy study models) and modest vasoactive effects at supraphysiological doses. Long-term behavioural support has reported context-dependent effects \u2014 e.g., increased in-group affiliation can be accompanied by increased out-group bias in some social-cognition paradigms. <\/p>\n<h3>How long does Oxytocin take to show effects in preclinical studies?<\/h3>\n<p>Acute behavioural effects on social-recognition, partner-preference, and trust-game paradigms are detectable within 30\u201360 minutes of intranasal administration in human and rodent studies. Peripheral effects (uterine contraction, milk-ejection) occur within seconds of intravenous administration due to direct OXTR coupling to PLC\/IP<sub>3<\/sub>\/Ca<sup>2+<\/sup> . <\/p>\n<h3>Posso ordinare Ossitocina Acetato per la spedizione internazionale?<\/h3>\n<p>S\u00ec. MedsBase spedisce Ossitocina Acetato in tutto il mondo dalla nostra rete dedicata di spedizione di peptidi. Gli ordini contenenti solo peptidi si qualificano per il nostro servizio di spedizione peptidi autonomo. Tutti gli ordini vengono spediti in imballaggi a temperatura controllata con tracciamento completo e sono coperti dal nostro <a href=\"https:\/\/medsbase.com\/it\/medsbase-re-shipment-assurance-policy\/\">Politica di Garanzia di Rispedizione<\/a>. <!-- medsbase-related-alts-v1 --><\/p>\n<h2>Other Peptides for CNS, Behavioural, and Affective Studies<\/h2>\n<ul>\n<li><a href=\"\/it\/selank\/\"><strong>Selank<\/strong><\/a> \u2014 Anxiolytic heptapeptide tuftsin analog \u2014 GABA\/BDNF stress resilience<\/li>\n<li><a href=\"\/it\/semax\/\"><strong>Semax<\/strong><\/a> \u2014 Eptapeptide nootropo sviluppato in Russia \u2014 modulazione melanocortinica e dopaminergica<\/li>\n<li><a href=\"\/it\/pt-141\/\"><strong>PT-141 (Bremelanotide)<\/strong><\/a> \u2014 Melanocortin receptor agonist \u2014 CNS-active small peptide for sexual-behaviour studies<\/li>\n<li><a href=\"\/it\/epitalon\/\"><strong>Epitalon<\/strong><\/a> \u2014 AEDG pineal tetrapeptide \u2014 longevity and circadian rhythm support<\/li>\n<li><a href=\"\/it\/bpc-157\/\"><strong>BPC-157<\/strong><\/a> \u2014 Body Protection Compound \u2014 tissue-recovery<\/li>\n<\/ul>\n<p><!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Approfondimenti<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Explore CNS-active peptides<\/strong><\/p>\n<p style=\"margin: 0;\">Sfoglia l'intera <a href=\"https:\/\/medsbase.com\/it\/peptides\/\"><strong>catalogo peptidi<\/strong><\/a>, con composti correlati tra cui <a href=\"https:\/\/medsbase.com\/it\/selank\/\">Selank<\/a> for anxiolytic GABA-axis studies, <a href=\"https:\/\/medsbase.com\/it\/semax\/\">Semax<\/a> for nootropic melanocortin-axis studies, and <a href=\"https:\/\/medsbase.com\/it\/pt-141\/\">PT-141<\/a> for melanocortin sexual-behaviour studies.<\/p>\n<\/div>\n<p><!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Neuropeptide ciclico a 9 amminoacidi<br \/>\n\u2705 Agonista del recettore OXTR<br \/>\n\u2705 Social-bonding &amp; affiliative behavioural support<br \/>\n\u2705 Peptide biodisponibile per via intranasale<br \/>\n\u2705 Forma di sale acetato \u2014 maggiore stabilit\u00e0<\/p>\n<p><strong>Ossitocina Acetato<\/strong> contiene composto peptidico sintetico.<\/p>","protected":false},"featured_media":70970,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[6274,5441],"class_list":["post-70705","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-oxytocin","product_tag-peptide","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product\/70705","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/comments?post=70705"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media\/70970"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/media?parent=70705"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_brand?post=70705"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_cat?post=70705"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/it\/wp-json\/wp\/v2\/product_tag?post=70705"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}